{"id":86864,"title":"Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman disease.","abstract":"","date":"2014-12-05","categories":"Virus Diseases","split":"train","url":"http://www.ncbi.nlm.nih.gov/pubmed/25331113","annotations":[{"name":"Doxorubicin","weight":0.906986,"wikipedia_article":"http://en.wikipedia.org/wiki/Doxorubicin"},{"name":"Castleman's disease","weight":0.904742,"wikipedia_article":"http://en.wikipedia.org/wiki/Castleman's_disease"},{"name":"Rituximab","weight":0.903192,"wikipedia_article":"http://en.wikipedia.org/wiki/Rituximab"},{"name":"Disease","weight":0.801843,"wikipedia_article":"http://en.wikipedia.org/wiki/Disease"},{"name":"Liposome","weight":0.745929,"wikipedia_article":"http://en.wikipedia.org/wiki/Liposome"}]}
